04 Jun 2021 by admin in UncategorizedComments Arcellx Announces Presentation of Positive Clinical Results from Ongoing Phase 1 Study of CART-ddBCMA at the 2021 ASCO Annual Meeting
20 May 2021 by admin in UncategorizedComments Crescendo Biologics announces initiation of Phase 1 study of CB307 in patients with advanced, PSMA-positive solid tumours
19 May 2021 by admin in UncategorizedComments NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
19 May 2021 by admin in UncategorizedComments Arcellx to Present Data from Phase 1 Study of CART-ddBCMA Demonstrating Continued Positive Response in Patients with Relapsed and Refractory Multiple Myeloma at the 2021 ASCO Annual Meeting
17 May 2021 by admin in UncategorizedComments Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates
13 May 2021 by admin in UncategorizedComments Preclinical Data of Arcellx’s Novel Synthetic CAR-T Binding Domain Presented at the 2021 ASGCT Annual Meeting and the 2021 PEGS Summit
12 May 2021 by admin in UncategorizedComments Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
10 May 2021 by admin in UncategorizedComments Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 May 2021 by admin in UncategorizedComments Crescendo Biologics further strengthens leadership team with appointment of Dr Michael Booth as Chief Financial Officer
08 May 2021 by admin in UncategorizedComments Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
06 May 2021 by admin in UncategorizedComments Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
03 May 2021 by admin in UncategorizedComments Zenas BioPharma Announces New Executive Leadership Appointments
19 Apr 2021 by admin in UncategorizedComments Crescendo Biologics and IAG partner to support the clinical development of CB307 with advanced imaging analysis technology
19 Apr 2021 by admin in UncategorizedComments Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China
16 Apr 2021 by admin in UncategorizedComments New data demonstrate that Humabodies® are highly effective in generating monospecific and bispecific CAR-T cells to target solid tumours
13 Apr 2021 by admin in UncategorizedComments Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies
13 Apr 2021 by admin in UncategorizedComments Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research
10 Apr 2021 by admin in UncategorizedComments NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR)
06 Apr 2021 by admin in UncategorizedComments Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma
30 Mar 2021 by admin in UncategorizedComments Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters
29 Mar 2021 by admin in UncategorizedComments Tempest and Millendo Announce Proposed Merger Agreement
26 Mar 2021 by admin in UncategorizedComments Design Therapeutics Announces Pricing of Initial Public Offering
22 Mar 2021 by admin in UncategorizedComments Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
11 Mar 2021 by admin in UncategorizedComments Adicet Reports Fourth Quarter and Full Year 2020 Financial results
10 Mar 2021 by admin in UncategorizedComments Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B
04 Mar 2021 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2020 Financial Results
04 Mar 2021 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial
03 Mar 2021 by admin in UncategorizedComments Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
02 Mar 2021 by admin in UncategorizedComments Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics
16 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private
10 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent
09 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private
02 Feb 2021 by admin in UncategorizedComments Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine
